Programs

To tackle the human health challenges that face the world today, the FNIH develops collaborations with top experts from government, industry, academia and the not-for-profit sector and provides a neutral environment where we can work productively toward a common goal.

Gene Drive Research Consortium
The FNIH periodically convenes technical experts to discuss issues related to the safe and effective use of gene drive technology.
Gene Drive Regulatory Network

The FNIH and collaborators are supporting regulatory capacity strengthening activities in anticipation of the potential testing and use of gene drive products.

Guidance, Recommendations and Best Practices Publications and Workshops

https://fnih.org/sites/default/files/final/pdf/Workbook%20and%20case%20study.pdfThe FNIH has worked and will continue to work with stakeholders and collaborators to support the development of best practices, guidance, and recommendations, as appropriate to the subject to inform gene drive research, development, testing and implementation, as well as to inform funders, regulators and other government authorities, policy makers, and international organizations, as appropriate.

The Moderate Alcohol and Cardiovascular Health Trial (MACH15)

The Moderate Alcohol and Cardiovascular Health Trial (MACH15) was a longitudinal, international clinical trial to determine the effects of moderate alcohol use on cardiovascular disease and diabetes. 

Fogarty International Center's 50th Anniversary

The National Institutes of Health (NIH)’s Fogarty International Center celebrated its 50th anniversary of accomplishments and hosted a Scientific Symposium on May 1st, 2018 at the Natcher Auditorium on NIH’s campus. The program convened a series of panel discussions with NIH leaders, Fogarty grantees, and key stakeholders, to identify key gaps in global health research and strategize future research initiatives.

Accelerating Medicines Partnership - Parkinson's Disease

In 2016, the AMP Executive Committee approved the planning of an AMP effort to confront the challenges presented by Parkinson’s disease (PD). This complements current efforts in the areas of Alzheimer’s disease, type 2 diabetes and the autoimmune disorders of rheumatoid arthritis and systemic lupus erythematosus (lupus). A critical component of this partnership is that all members have agreed to make the AMP Parkinson’s disease (AMP PD) data and analyses publicly available to the broad biomedical community.

Support functions for development of new technologies for controlling transmission of mosquito-borne diseases

The project provides the FNIH management and advisory services for research programs seeking to develop new cost-effective and sustainable biologic strategies for controlling mosquito-borne infections like malaria and dengue fever.

FNIH Trailblazer Prize for Clinician-Scientists

The FNIH Trailblazer Prize for Clinician-Scientists (Trailblazer Prize), recognizes the outstanding contributions of early career clinician-scientists whose research has the potential to or has led to innovations in patient care.

Gene Drive Research Forum

The FNIH and other organizations that support or sponsor gene drive research convened in 2017 and 2018  to discuss the status and challenges of gene drive research, identify areas of potential mutual interest and facilitate collaboration, coordination and cooperation.

The Biomedical Research Community Responds to the Opioids Crisis

As part of a larger national effort to address the opioid crisis, the FNIH is leading the planning effort for a potential public-private scientific partnership that includes the NIH, FDA, the Pharmaceutical Research and Manufacturers of America (PhRMA) and more than 30 biopharmaceutical companies.